A multicenter, fixed-flexible dose study of terazosin hydrochloride in the treatment of symptomatic benign prostatic hypertrophy

In this study the multicenter, fixed-flexible dose regimen was taken to evaluate the effective dose range of Terazosin for the treatment of micturition disturbance in benign prostatic hypertrophy (BPH) and to clarify the characteristics of patients who are more responsive to Terazosin therapy. After...

Description complète

Détails bibliographiques

Publié dans:	Hinyokika kiyo. Acta urologica Japonica. - 1962. - 38(1992), 7 vom: 01. Juli, Seite 857-68
Auteur principal:	Park, Y C (Auteur)
Autres auteurs:	Nishioka, T, Arai, Y, Tomoyoshi, T, Kurita, T, Hayashida, H, Nagai, N, Inoue, H, Kataoka, K, Kitagawa, Y
Format:	Article
Langue:	Japanese
Publié:	1992
Accès à la collection:	Hinyokika kiyo. Acta urologica Japonica
Sujets:	Clinical Trial English Abstract Journal Article Multicenter Study Adrenergic alpha-Antagonists Terazosin 8L5014XET7 Prazosin XM03YJ541D